Search Results
May 29, 2025, 03:18 ET FLOKI and New to The Street Announce Media Partnership to Reach 219M+ Households
Bloomberg, with another 50 ads on Bloomberg kicking off in month two. Three press releases per month, NYSE interview recaps, and targeted pitches to ABC, NBC, CBS, and FOX affiliates will amplify FLOKI's reach beyond crypto circles. All content will be posted across New to The Street's
More news about: FLOKI
May 28, 2025, 08:00 ET The Journey of King Moore: From a Toddler with a Dream to the Big Stage
face has graced national commercials for AT&T and Toyota. He's appeared twice on the Tamron Hall Show (ABC/Disney), as well as the Portia Bruner Show (Fox). He's toured with stars like That Girl Lay Lay, Kenan
More news about: King Moore World Inc.
May 26, 2025, 11:47 ET Para ABC Brasil a COP30 deve acelerar a adaptação das empresas na transição para uma economia de baixo carbono
colher os frutos de um mercado global cada vez mais consciente e exigente", avalia Fabiana Silva, Head de ESG do Banco ABC Brasil. As novas exigências regulatórias surgem em um contexto no qual a comunidade internacional, especialmente os países mais desenvolvidos,
More news about: Banco ABC Brasil
May 25, 2025, 09:39 ET Menarini Group stellt auf der ASCO-Jahrestagung 2025 aktualisierte Daten vor, die die Kombinierbarkeit von Elacestrant (ORSERDU®) bei Patientinnen mit ER+, HER2- metastasiertem Brustkrebs (mBC) unterstreichen
Phase-3-Studie zu Elacestrant (ELA) + Everolimus (EVE) im Vergleich zu ELA + Placebo (PBO) bei Patientinnen mit ER+/HER2-fortgeschrittenem Brustkrebs (aBC) mit ESR1-mutierten Tumoren, die unter endokriner Therapie (ET) + CDK4/6i fortgeschritten sind.Abstract-Nummer: TPS1129Datum
More news about: Menarini Industrie Farmaceutiche Riunite
May 25, 2025, 09:25 ET Menarini Group presenta datos actualizados que destacan la capacidad de combinación de elacestrant (ORSERDU®) en pacientes con cáncer de mama metastásico (CMM) ER+, HER2- en la reunión anual de la ASCO de 2025
breast cancer (aBC) patients with ESR1-mutated tumors progressing on endocrine therapy (ET) + CDK4/6i (ADELA: ensayo de fase 3 aleatorizado, doble ciego y controlado con placebo de elacestrant (ELA) + everolimus (EVE) frente a ELA + placebo (PBO) en pacientes con cáncer de mama avanzado (aBC) ER+/HER2- con
More news about: Menarini Industrie Farmaceutiche Riunite
May 24, 2025, 08:52 ET 在 2025 年 ASCO 年會中，Menarini Group 隆重發表 ER+ 和 HER2- 轉移性乳癌 (mBC) 患者接受 Elacestrant (ORSERDU®) 結合治療的更新數據
58講者：Nancy Chan 簡報題目：ADELA：一項雙盲、安慰劑對照、隨機第 3 期試驗，針對內分泌治療 (ET) + CDK4/6i 後病情進展的 ER+/HER2- 晚期乳癌 (aBC) ESR1 基因突變腫瘤患者，進行 Elacestrant (ELA) + everolimus (EVE) 對照 ELA + 安慰劑 (PBO) 的試驗。摘要編號：TPS1129 演講日期及時間：6 月 2 日（星期一）上午 9:00
More news about: Menarini Industrie Farmaceutiche Riunite
May 23, 2025, 09:11 ET Menarini Group presenta datos actualizados en la Reunión Anual de ASCO 2025
placebo-controlled, randomized phase 3 trial of Elacestrant (ELA) + everolimus (EVE) versus ELA + placebo (PBO) in ER+/HER2- advanced breast cancer (aBC) patients with ESR1-mutated tumors progressing on endocrine therapy (ET) + CDK4/6i.Número de resumen: TPS1129Fecha y hora
More news about: Menarini Industrie Farmaceutiche Riunite
May 23, 2025, 05:36 ET Il Gruppo Menarini presenta nuovi dati che evidenziano la capacità di combinazione di Elacestrant (ORSERDU®) in pazienti con carcinoma mammario metastatico ER+, HER2- (mBC) al Congresso Annuale ASCO 2025
doppio cieco e controllato con placebo, di elacestrant (ELA) + everolimus (EVE) verso ELA + placebo (PBO) in pazienti con carcinoma mammario avanzato (aBC) ER+/HER2- con tumori ESR1 mutati in progressione a terapia endocrina (ET) + inibitori CDK4/6.Numero abstract: TPS1129Data
More news about: Menarini Industrie Farmaceutiche Riunite
May 23, 2025, 05:17 ET Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
placebo-controlled, randomized phase 3 trial of Elacestrant (ELA) + everolimus (EVE) versus ELA + placebo (PBO) in ER+/HER2- advanced breast cancer (aBC) patients with ESR1-mutated tumors progressing on endocrine therapy (ET) + CDK4/6i.Abstract Number: TPS1129Presentation Date
More news about: Menarini Industrie Farmaceutiche Riunite
May 23, 2025, 04:58 ET Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
placebo-controlled, randomized phase 3 trial of Elacestrant (ELA) + everolimus (EVE) versus ELA + placebo (PBO) in ER+/HER2- advanced breast cancer (aBC) patients with ESR1-mutated tumors progressing on endocrine therapy (ET) + CDK4/6i.Abstract Number: TPS1129Presentation Date
More news about: Menarini Industrie Farmaceutiche Riunite
May 22, 2025, 17:05 ET Lilly announces details of presentations at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
3 EMBER-3 trial in patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer (ABC), and a poster presentation will feature expanded EMBER-3 safety analyses. Olomorasib (investigational KRAS G12C inhibitor):In
More news about: Eli Lilly and Company
May 22, 2025, 14:24 ET CEO speech to the Annual General Meeting 2025 of Minesto AB
https://news.cision.com/minesto-ab/r/ceo-speech-to-the-annual-general-meeting-2025-of-minesto-ab,c4154482
More news about: Minesto AB
May 22, 2025, 14:20 ET CEO speech to the Annual General Meeting 2025 of Minesto AB
https://news.cision.com/minesto-ab/r/ceo-speech-to-the-annual-general-meeting-2025-of-minesto-ab,c4154482
More news about: Minesto AB
May 22, 2025, 09:12 ET Lexus Named Official Automotive Partner of Premier Lacrosse League
(CAA), The Kraft Group, Bolt Capital and other top investors in sports and media. The PLL is distributed through an exclusive media rights agreement with ABC, ESPN, ESPN2, and ESPN+. The PLL was named 2023 Best Place to Work in Sports, and 2020 Sports Breakthrough by the Sports Business Journal, and recognized
More news about: Premier Lacrosse League
May 22, 2025, 07:50 ET Report from the Annual General Meeting 2025 of Minesto AB
https://news.cision.com/minesto-ab/r/report-from-the-annual-general-meeting-2025-of-minesto-ab,c4154246 The following files are available for download:
More news about: Minesto AB
May 21, 2025, 13:05 ET UPPAbaby Finalizes 4moms Brand Integration, Uniting Two Industry Leaders Under One Umbrella
that need head-on with a full portfolio that simplifies daily life, while simultaneously elevating it." The announcement was made at the recent ABC Kids Expo in Las Vegas, NV, where UPPAbaby unveiled upcoming product developments and offered a first look at its expanded
More news about: UPPAbaby
May 21, 2025, 12:15 ET Maxi-Cosi Expands into the Nursery Furniture Category Unveiling Seven Collections at ABC Kids Expo
manufacturer, today announced the expansion of its Maxi-Cosi brand into nursery furniture with the introduction of four distinct collections. Debuting at ABC Kids Expo, Kindred Walnut Ash, Kindred Whitewash Ash, Quiet Luxury, and Embraced Forms, along with three additional collections, represent an elevated
More news about: Dorel Juvenile
May 21, 2025, 09:00 ET Rebel Bourbon and Childress Vineyards introduce Rebel 100 Childress Vineyards Cabernet Franc Barrel Finish
bright berries. An allocation of 500 cases (6-in) of Rebel 100 Childress Vineyards Cabernet Franc Barrel Finish will be available at North Carolina ABC stores and at Lux Row Distillers beginning this month at a minimum suggested retail price of $39.99 per 750mL bottle.
More news about: Lux Row Distillers
May 21, 2025, 06:27 ET ALLIANCE FOR WOMEN IN MEDIA FOUNDATION'S 50TH ANNUAL GRACIE AWARDS CELEBRATED FIVE DECADES OF HONORING TRAILBLAZING WOMEN IN MEDIA
Stanley, CNN, FOX Sports, CBS News, NBC Sports, Bloomberg, Hallmark Media, Jamie Kern Lima, NBC Entertainment, Hempz, ABC News, ESPN, and FarmHouse Fresh. The Gracie Awards Gala will be produced by female-owned production companies, and all-female production teams
More news about: Alliance for Women in Media Foundation
May 19, 2025, 10:07 ET The National Lipid Association (NLA) and Foundation of the National Lipid Association (FNLA) Urge CMS and Administrator Oz to Include Low-Density Lipoprotein Cholesterol (LDL-C) Measurement in CMS Quality Measurement Programs
Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/ APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association
More news about: National Lipid Association
May 19, 2025, 08:42 ET Jam Vino Takes National Stage on the Mother's Day Edition of "The View" on ABC
"Favorite Things" on the May 6th Mother's Day Edition of the 30-time Emmy® Award-winning daytime talk show on ABC. "I'm overwhelmed with gratitude," said Chef Lori Rogers, founder and CEO of Jam Vino. "To have our jam presented
More news about: Chef Lorious Group, LLC
May 19, 2025, 06:41 ET Anuncian la primera lista de largometrajes impulsados por IA en Cannes
Conjuring Universe y Pros vs Joes, hasta la producción de IPs tan queridas como la serie original de Sabrina, la Bruja Adolescente, en horario principal en ABC, y el clásico de culto Josies and The Pussycats, sus obras han generado miles de millones de dólares en ingresos globales. Sitio web de Visual
More news about: Visual Alchemy LLC; Intelliflicks
May 19, 2025, 04:03 ET HOLLYWOOD DISRUPTED: FORMER MICROSOFT VP'S AI STUDIO AND CONJURING CREATOR ANNOUNCE FIRST EVER AI-DRIVEN FEATURE SLATE AT CANNES
creators. From launching The Conjuring Universe and Pros vs Joes, to producing beloved IPs like the original Sabrina the Teenage Witch primetime series on ABC to the cult classic Josies and The Pussycats move, his works have earned billions in global revenues Visual Alchemy website:
More news about: Visual Alchemy LLC; Intelliflicks
May 19, 2025, 04:03 ET HOLLYWOOD DISRUPTED: FORMER MICROSOFT VP'S AI STUDIO AND CONJURING CREATOR ANNOUNCE FIRST EVER AI-DRIVEN FEATURE SLATE AT CANNES
creators. From launching The Conjuring Universe and Pros vs Joes, to producing beloved IPs like the original Sabrina the Teenage Witch primetime series on ABC to the cult classic Josies and The Pussycats move, his works have earned billions in global revenues Visual Alchemy website:
More news about: Visual Alchemy LLC; Intelliflicks
May 19, 2025, 04:03 ET HOLLYWOOD IM UMBRUCH: DAS KI-STUDIO DES EHEMALIGEN MICROSOFT-VICE PRESIDENT UND DER SCHÖPFER VON CONJURING GEBEN IN CANNES DIE ERSTE KI-BASIERTE FILMREIHE BEKANNT
„The Conjuring Universe" und „Pros vs Joes" über die Produktion beliebter IPs wie der ursprünglichen Primetime-Serie „Sabrina the Teenage Witch" auf ABC bis hin zum Kultklassiker „Josies and The Pussycats" haben seine Werke weltweit Milliardenumsätze erzielt. Website von Visual Alchemy:
More news about: Visual Alchemy LLC; Intelliflicks